Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00008
|
|||||
| Drug Name |
Venetoclax
|
|||||
| Synonyms |
Venclexta
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic lymphocytic leukemia [ICD11: 2A82.0] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C45H50ClN7O7S
|
|||||
| Canonical SMILES |
CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
|
|||||
| InChI |
InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)
|
|||||
| InChIKey |
LQBVNQSMGBZMKD-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 1257044-40-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 868.4 | Topological Polar Surface Area | 183 | ||
| Heavy Atom Count | 61 | Rotatable Bond Count | 12 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 11 | |||
| XLogP |
8.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
104174762
, 121138507
, 163620947
, 163643283
, 163686269
, 164194131
, 172821369
, 174006982
, 184826868
, 184826869
, 194147759
, 198955872
, 198994028
, 223704851
, 225848221
, 226835897
, 242587479
, 244605658
, 251910672
, 251970551
, 252126157
, 252151319
, 252160763
, 252166530
, 252214644
, 252269026
, 252446873
, 252450873
, 252552037
, 252810258
, 252819663
|
|||||
| ChEBI ID |
CHEBI:133021
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Venetoclax was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Venclexta FDA label | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.